Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplification. [electronic resource]
Producer: 20210910Description: 1633-1640 p. digitalISSN:- 1573-0646
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Oncogenes
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Pyrrolidinones -- pharmacology
- Quinolines -- pharmacology
- Sequence Analysis, RNA
- Stomach Neoplasms -- drug therapy
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.